Pharmaceutical & life sciences
GDP-validated storage, vaccine cold chain & biotech
Validated +2/+8 °C and −20 °C facilities for distributors, manufacturers and hospital networks. Built for 21 CFR Part 11 and WHO GDP audits.
Key challenges
- Zero-deviation temperature performance
- Validation, mapping and qualification timelines
- Redundancy in high-ambient regions
ColdMatch solutions
- N+1 redundant chillers with backup generation
- Validated mapping, alarms and 24/7 monitoring
- Cleanroom-compatible MEP coordination
Typical projects & capex
| Project type | Capex range |
|---|---|
| Pharmacy chamber | $50K – $250K |
| Vaccine distribution hub | $2M – $12M |
| Biotech storage + −80 °C | $1M – $8M |
Frequently asked questions — Pharmaceutical & life sciences
Does ColdMatch source GDP-validated pharma warehouses?+
Yes. Every pharma project is shortlisted to suppliers with documented GDP, GMP, ISO 9001 and (where required) FDA-compliant project history.
Can we get redundant cooling for vaccine and biologics storage?+
All pharma proposals default to N+1 redundancy, backup generation and validated 21 CFR Part 11 monitoring. We won't shortlist suppliers that can't deliver this.
How long does validation and licensing typically take?+
Mapping, qualification and ministry licensing usually run 4–8 months in parallel with construction. ColdMatch coordinates the EPC + validation provider to compress this timeline.
Can ColdMatch help finance a pharma cold-storage build?+
Yes — equipment leasing, ECA-backed loans and project financing are available from $500K to $50M. See the financing page.